Tag: Competition

Displaying 221 - 240 of 4041 results.

Pages

Filtering by content type: Public Statement

Filtering by content type: Press Release

The Federal Trade Commission and the U.S. Department of Justice Antitrust Division today issued joint statement detailing an expedited antitrust procedure and providing guidance for collaborations of businesses working to protect the health and safety of Americans during the COVID-19 pandemic.
The staff of Federal Trade Commission’s Office of Policy Planning, Bureau of Economics, and Bureau of Competition, together with the staff of the Antitrust Division of the Department of Justice, have submitted a letter to California State Assembly Member Jim Wood raising concerns that California...
Danaher Corporation has agreed to divest assets to settle Federal Trade Commission charges that its proposed $21.4 billion acquisition of General Electric’s biopharmaceutical business, GE Biopharma, would violate federal antitrust law.
Federal Trade Commission Executive Director David B. Robbins issued the following statement:The FTC is taking a variety of measures to respond to the new and challenging circumstances associated with the COVID-19 coronavirus crisis.  Our two main priorities, as always, are: the health and safety of...

Filtering by content type: Federal Register Notice

Filtering by content type: Case

Danaher Corporation has agreed to divest assets to settle Federal Trade Commission charges that its proposed $21.4 billion acquisition of General Electric’s biopharmaceutical business, GE Biopharma, would violate federal antitrust law.

Filtering by content type: Advocacy Filing

Comment by FTC and DOJ staff in response to invitation from California Assembly Member Jim Wood concerning the likely competitive effects of A.B.1541, a proposal to further restrict contracting between beer manufacturers and beer wholesalers.

Filtering by content type: Advisory Opinion

Manufacturing of polypropylene using propylene as a feedstock constitutes "petrochemical processing" and is an "oil and gas related asset" within the meaning of the Consent Order issued against respondent, Decisions Volume 104
Proposed development of a relative value guide for physician services to be distributed to member internists would be likely to have anticompetitive effects that probably would not be outweighed by any counterveiling efficiency justifications, Decisions Volume 105
Proposed barter program with foreign countries for phosphate rock would avoid respondent's involvement in other than export trade and falls under the protection of the Webb-Pomerene Act, Decisions Volume 108
Proposed acquisition by Coca-Cola would require prior Commission approval under the Commission's order of August 3, 1983, Decisions Volume 111
The proposed Code of Conduct of the Association of Trial Lawyers of America does not appear likely to have a significant anticompetitive effect and therefore, to violate Section 5 of the FTC Act, Decisions Volume 114
Re: The application of the Non-Profit Institutions Act to sales of pharmaceuticals by non-profit hospitals to related non-profit long-term care facilities, Decisions Volume 116
Re: A program proposed by the American Medical Association and the Chicago Medical Society involving peer review of physician fees is not likely to violate antitrust laws, Decisions Volume 117
Due to insufficient information supplied by respondent SCM Corporation, Commission was unable to determine whether proposed interlocking directorate would violate provisions of Final Order entered against SCM, Decisions Volume 103
Re: The proposal to adopt and enforce certain accrediting standards on tuition and fees would not violate antitrust laws, Decisions Volume 119

Filtering by content type: Blog Post

Like many other agencies, organizations, and employers across the country, we in the Bureau of Competition are adjusting to the realities of working during the COVID-19 coronavirus crisis. As part of that adjustment, we are taking a variety of measures to respond to these new and...

Pages